Physician profile
Patrick J Strollo
NPI 1891760740
$123,712.84
in general payments reported to CMS, 2019-2025
6 companies · $3,448 in 2025
The $3,448 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23K · 2022: $42K · 2023: $24K · 2024: $31K · 2025: $3,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Consulting Fee: $8,825 · Long Term Medical Supply Or Device Loan: $6,906 · Honoraria: $1,440 · Travel and Lodging: $837 · Food and Beverage: $70.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,999.99 |
| Consulting Fee | $8,825.00 |
| Long Term Medical Supply Or Device Loan | $6,906.30 |
| Honoraria | $1,440.00 |
| Travel and Lodging | $837.37 |
| Food and Beverage | $70.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Belluscura LLC | $103,333.32 | 2021-2024 | |
| Philips North America LLC | $10,646.30 | 2022-2025 | (3237) Ca Undiv, Coughassist 2 |
| Eli Lilly and Company | $8,514.17 | 2024 | Mounjaro |
| Aerin Medical INC. | $1,000.00 | 2025 | |
| Inspire Medical Systems, INC. | $184.05 | 2023-2025 | Inspire |
| Lilly USA, LLC | $35.00 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Strollo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.